Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
Go back to Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates| (NASDAQ: VRDN) | Delayed: 19.40 +0.92 (4.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.48 | 52 Week High | $ | |||
| Open | $18.69 | 52 Week Low | $ | |||
| Day High | $19.42 | P/E | N/A | |||
| Day Low | $18.51 | EPS | $ | |||
| Volume | 1,950,334 | |||||

